Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
4.190
-0.080 (-1.87%)
At close: Aug 10, 2026, 4:00 PM EDT
4.160
-0.030 (-0.72%)
After-hours: Aug 10, 2026, 7:43 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $2.02 million as of August 10, 2026. Its market cap has decreased by -65.83% in one year.
Market Cap
2.02M
Enterprise Value
-16.03M
1-Year Change
-65.83%
Ranking
Category
Stock Price
$4.19
ChartMarket Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.40M to $2.02M, a decrease of -82.31%. That is a compound annual growth rate of -18.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.00M | -50.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.00% |
| Dec 31, 2021 | 62.70M | -61.84% |
| Dec 31, 2020 | 164.30M | 3,121.57% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 45.61% |
| Mar 29, 2018 | 11.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 2.51M |
| Oragenics | 2.48M |
| Clearmind Medicine | 2.42M |
| Virax Biolabs Group | 2.38M |
| Azitra | 2.19M |
| Moleculin Biotech | 2.19M |
| CDT Equity | 2.16M |
| Decoy Therapeutics | 2.09M |